Free
About
A three-year, non-interventional, prospective, multicenter study to evaluate the long-term effectiveness of lanadelumab in real-world clinical practice (ENABLE)
What's New in ENABLE (SHP643
1.6
September 24, 2024
- updates to assessment availability at certain visits
